MFA
ZURA icon

Millington Financial Advisors’s Zura Bio ZURA Stock Holding History

Millington Financial Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,574
Closed -$59.2K – 92
2024
Q3 		$59.2K Buy
+14,574
New +$54.4K 0.04% 82

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millington Financial Advisors's ZURA Position: Q4 2024 in Review

Millington Financial Advisors sold out of Zura Bio (ZURA) in Q4 2024, closing a stake of 14,574 shares — an estimated $59.2K sold.

Millington Financial Advisors first reported a position in ZURA in Q3 2024 and held it in 1 quarter. The position peaked at $59.2K in Q3 2024. 87 funds tracked by Wall St. Rank hold ZURA as of Q4 2024.

  • Millington Financial Advisors reported no remaining Zura Bio position as of Q4 2024 after selling out during the quarter.
  • Millington Financial Advisors sold 14,574 Zura Bio shares in Q4 2024, an estimated $59.2K.
  • Millington Financial Advisors first reported a position in Zura Bio in Q3 2024 and held it in 1 quarter.
  • Millington Financial Advisors's Zura Bio position peaked at $59.2K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held Zura Bio as of Q4 2024.

Based on Millington Financial Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.